Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Collective rotational motion of freely expanding T84 epithelial cell colonies.
Ascione F, Caserta S, Esposito S, Villella VR, Maiuri L, Nejad MR, Doostmohammadi A, Yeomans JM, Guido S. Ascione F, et al. Among authors: villella vr. J R Soc Interface. 2023 Feb;20(199):20220719. doi: 10.1098/rsif.2022.0719. Epub 2023 Feb 22. J R Soc Interface. 2023. PMID: 36872917 Free PMC article.
Succinate links mitochondria to deadly bacteria in cystic fibrosis.
Esposito S, Villella VR, Rossin F, Tosco A, Raia V, Luciani A. Esposito S, et al. Among authors: villella vr. Ann Transl Med. 2019 Dec;7(Suppl 8):S263. doi: 10.21037/atm.2019.12.49. Ann Transl Med. 2019. PMID: 32015982 Free PMC article. No abstract available.
The STING/TBK1/IRF3/IFN type I pathway is defective in cystic fibrosis.
Occhigrossi L, Rossin F, Villella VR, Esposito S, Abbate C, D'Eletto M, Farrace MG, Tosco A, Nardacci R, Fimia GM, Raia V, Piacentini M. Occhigrossi L, et al. Among authors: villella vr. Front Immunol. 2023 Feb 27;14:1093212. doi: 10.3389/fimmu.2023.1093212. eCollection 2023. Front Immunol. 2023. PMID: 36923406 Free PMC article.
L1077P CFTR pathogenic variant function rescue by Elexacaftor-Tezacaftor-Ivacaftor in cystic fibrosis patient-derived air-liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients.
Lo Cicero S, Castelli G, Blaconà G, Bruno SM, Sette G, Pigliucci R, Villella VR, Esposito S, Zollo I, Spadaro F, Maria R, Biffoni M, Cimino G, Amato F, Lucarelli M, Eramo A. Lo Cicero S, et al. Among authors: villella vr. Respir Res. 2023 Sep 6;24(1):217. doi: 10.1186/s12931-023-02516-0. Respir Res. 2023. PMID: 37674160 Free PMC article.
Correction to: L1077P CFTR pathogenic variant function rescue by Elexacaftor-Tezacaftor-Ivacaftor in cystic fbrosis patient-derived air-liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients.
Lo Cicero S, Castelli G, Blaconà G, Bruno SM, Sette G, Pigliucci R, Villella VR, Esposito S, Zollo I, Spadaro F, De Maria R, Biffoni M, Cimino G, Amato F, Lucarelli M, Eramo A. Lo Cicero S, et al. Among authors: villella vr. Respir Res. 2023 Sep 23;24(1):228. doi: 10.1186/s12931-023-02535-x. Respir Res. 2023. PMID: 37742000 Free PMC article. No abstract available.
48 results